课题基金 / 基金详情

Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells

Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells
阐明巨噬细胞介导的异种移植排斥的机制以及通过将人 CD47 基因引入异种细胞来预防巨噬细胞介导的异种移植排斥的新方法
批准号:
16591257
负责人:
OHDAN Hideki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OHDAN Hideki的其他基金

相似基金

相关文献

中文摘要
翻译
将猪的器官移植给人类是解决供体器官短缺的一种可能方案。尽管宿主巨噬细胞至少部分参与了移植异种细胞的快速清除,但巨噬细胞诱导异种细胞杀伤的机制尚未完全阐明。我们证明了人网状内皮巨噬细胞可以在没有抗体或补体调理作用的情况下吞噬猪细胞,并且去除猪细胞中的α1,3-半乳糖基异种抗原并不能阻止这种吞噬。我们还证明了CD47的种间不相容显著促进了巨噬细胞对异种细胞的吞噬。为了进一步确定人CD47在猪细胞上的表达是否对人巨噬细胞的吞噬具有保护作用,我们通过将人CD47表达质粒导入猪B淋巴瘤样细胞,建立了表达人CD47的猪细胞系。人CD47在猪细胞上的表达从根本上降低了细胞对人网状内皮巨噬细胞吞噬的敏感性,无论有没有抗体调理。这些结果表明CD47的种间不亲和性在巨噬细胞对异种细胞的排斥反应中起重要作用。猪细胞表达CD47的基因操作可能通过抑制CD47-Sirpα信号通路,为预防巨噬细胞介导的异种移植排斥反应提供新的途径。
英文摘要
Xenotransplantation of pig organs to humans is a possible solution for the shortage of donor organs for transplantation. Although host macrophages are known to contribute at least in part to rapid clearance of transplanted xenogeneic cells, the mechanisms underlying macrophage-induced killing of xenogeneic cells has not been fully addressed. We here demonstrated that human reticulo-endothelial macrophages can phagocytose porcine cells in the absence of antibody or complement opsonization, and that the removal of α1,3-galactosyl xenoantigens from the porcine cells failed to prevent the phagocytosis. We also demonstrated that the interspecies incompatibility of CD47 significantly contributes to the phagocytosis of xenogeneic cells by macrophages. To further determine whether the expression of human CD47 on porcine cells could confer protection from phagocytosis by human macrophages, we generated human CD47-expressing porcine cell lines by transfecting the porcine B lymphoma-like cells with a human CD47 expressing plasmid. Human CD47 expression on porcine cells radically reduced the susceptibility of the cells to phagocytosis by human reticulo-endothelial macrophages, regardless of the presence or absence of antibody opsonization. These results indicate that the interspecies incompatibility of CD47 significantly contributes to the rejection of xenogeneic cells by macrophages. Genetic manipulation of porcine cells for expression of human CD47 may provide a novel approach in preventing macrophage-mediated xenograft rejection through inhibitory CD47-SIRPα signaling.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1399-3089.2005.00222.x
发表时间: 2005-05-01
期刊: XENOTRANSPLANTATION
影响因子: 3.9
作者: [Ide, K, Ohdan, H, Asahara, T]
通讯作者: Asahara, T
Development of a novel desensitization/immune-regulatory method by use of multi-potent suppressor B cells to induce immune-tolerance in allogeneic organ transplantation
  • 批准号:
    15H02555
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 资助金额:
    $26.62万
  • 财政年份:
    2015
  • 负责人:
    OHDAN Hideki
  • 依托单位:
Development of novel cell therapeutic strategy using unlicenced NK cells combined with molecular target medicine for liver cancer
  • 批准号:
    25670581
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2013
  • 负责人:
    OHDAN Hideki
  • 依托单位:
The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells
  • 批准号:
    23249064
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 资助金额:
    $30.87万
  • 财政年份:
    2011
  • 负责人:
    OHDAN Hideki
  • 依托单位:
Establishment of strategies to regulate antibody-mediated rejection on the basis of B cell differentiation biology
  • 批准号:
    23659614
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2011
  • 负责人:
    OHDAN Hideki
  • 依托单位:
国内基金
海外基金
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
  • 批准号:
    81102247
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2011
  • 负责人:
    丁晨光
  • 依托单位: